Myovant Sciences Ltd – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/22 Q3

ended 09/30/22 Q2

ended 06/30/22 Q1

ended 03/31/22 FY 2022

ended 12/31/21 Q3

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Potter Myrtle S

Merendino Lauren

News Filter

Sumitovant Biopharma Completes Acquisition of Myovant Sciences

Shareholder Vote Results

Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022

Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022

Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter Into Definitive Agreement

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Preliminary revised proxy

Preliminary proxy related to merger

Other Filter

Notice of effectiveness

Notice of effectiveness

Confidential treatment order

Correspondence with the SEC

Letter from the SEC